These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


359 related items for PubMed ID: 12090084

  • 1. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS, Patel A.
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [Abstract] [Full Text] [Related]

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Mar; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM.
    J Infect Dis; 2001 May 01; 183(9):1399-404. PubMed ID: 11294673
    [Abstract] [Full Text] [Related]

  • 6. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S, Badelon I, Chaine G.
    J Fr Ophtalmol; 1998 Jan 01; 21(1):34-41. PubMed ID: 9834898
    [Abstract] [Full Text] [Related]

  • 7. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK.
    Am J Ophthalmol; 2005 Jun 01; 139(6):1028-34. PubMed ID: 15953432
    [Abstract] [Full Text] [Related]

  • 8. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A, Moe AA, Miller MJ, Wagar EA, Bruckner DA, Holland GN.
    Ophthalmology; 1999 Jan 01; 106(1):133-41. PubMed ID: 9917794
    [Abstract] [Full Text] [Related]

  • 9. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038
    [Abstract] [Full Text] [Related]

  • 10. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 01; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 11. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 12. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
    Kappel PJ, Charonis AC, Holland GN, Narayanan R, Kulkarni AD, Yu F, Boyer DS, Engstrom RE, Kuppermann BD, Southern California HIV/Eye Consortium.
    Ophthalmology; 2006 Apr 03; 113(4):683.e1-8. PubMed ID: 16581428
    [Abstract] [Full Text] [Related]

  • 13. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
    Jabs DA, Ahuja A, Van Natta ML, Lyon AT, Yeh S, Danis R, Studies of the Ocular Complications of AIDS Research Group.
    Ophthalmology; 2015 Jul 03; 122(7):1452-63. PubMed ID: 25892019
    [Abstract] [Full Text] [Related]

  • 14. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Rudent A, Lantz O, Lecointe D, Furlan V, Delfraissy JF, Offret H.
    J Fr Ophtalmol; 1998 Oct 03; 21(8):567-76. PubMed ID: 9833222
    [Abstract] [Full Text] [Related]

  • 15. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Hsieh SM, Pan SC, Hung CC, Tsai HC, Chen MY, Chang SC.
    J Infect Dis; 2001 Dec 01; 184(11):1386-91. PubMed ID: 11709780
    [Abstract] [Full Text] [Related]

  • 16. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA, Studies of Ocular Complications of AIDS Researh Group.
    Ophthalmology; 2003 May 01; 110(5):987-95. PubMed ID: 12750102
    [Abstract] [Full Text] [Related]

  • 17. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 May 01; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 18. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ciulla TA, Rutledge BK, Morley MG, Duker JS.
    Ophthalmic Surg Lasers; 1998 Mar 01; 29(3):198-206. PubMed ID: 9547773
    [Abstract] [Full Text] [Related]

  • 19. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA, Kendall MA, Owens S, Holland G, Nokta M, Spector SA, Schrier R, Fiscus S, Davis M, Jacobson MA, Currier JS, Squires K, Alston-Smith B, Andersen J, Freeman WR, Higgins M, Torriani FJ, ACTG 379 Study Team.
    HIV Clin Trials; 2005 Mar 01; 6(3):136-46. PubMed ID: 16192248
    [Abstract] [Full Text] [Related]

  • 20. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH, Min YI, Freeman WR, Holland GN, Friedberg DN, Dieterich DT, Jabs DA, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Apr 01; 113(4):684-94. PubMed ID: 16581429
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.